Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

NCRI 2012 /
New genetic sub-types of breast, ovarian and prostate cancer

4th - 7th Nov 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.11.12
Views: 5399

Dr Paul Pharoah – University of Cambridge, UK

Dr Paul Pharoah discusses research assessing genetic material from several hundred cancer patients across world. This study has identified many new genetic sub-types associated with breast, ovarian and prostate cancer risk and has many potential clinical benefits such as improvements in the effectiveness of breast or prostate cancer screening programmes or the identification of new targets for personalised medicines.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation